Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * allow: |
Title | EPM - Medicine to |
Description | EPM is leading the way in next-generation cannabinoid acid medicine - unlocking its full potential to address unmet patient and consumer |
Keywords | Unlock the potential, Novel therapeutics, Synthetic, Cannabinoid acids, Patient-focused, Pharmaceutical Group, prescription medicine, Lab-made, FDA Guidelines, alternative treatments, Minimal side effects, Alternative to steroids |
WebSite | epmip.com |
Host IP | 76.76.21.21 |
Location | United States |
Site | Rank |
US$4,332,411
Last updated: 2023-05-08 23:06:12
epmip.com has Semrush global rank of 2,443,052. epmip.com has an estimated worth of US$ 4,332,411, based on its estimated Ads revenue. epmip.com receives approximately 499,894 unique visitors each day. Its web server is located in United States, with IP address 76.76.21.21. According to SiteAdvisor, epmip.com is safe to visit. |
Purchase/Sale Value | US$4,332,411 |
Daily Ads Revenue | US$4,000 |
Monthly Ads Revenue | US$119,975 |
Yearly Ads Revenue | US$1,439,694 |
Daily Unique Visitors | 33,327 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
epmip.com. | A | 598 | IP: 76.76.21.21 |
epmip.com. | NS | 3600 | NS Record: ns76.domaincontrol.com. |
epmip.com. | NS | 3600 | NS Record: ns75.domaincontrol.com. |
epmip.com. | MX | 3600 | MX Record: 0 epmip-com.mail.protection.outlook.com. |
epmip.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
About Our Story Board of Directors Executive Leadership Advisory Board Treatments Current Developments Prader-Willi Syndrome Psoriasis Inflammatory Bowel Disease Science About Cannabiniod Acids Pipeline Key Collaborations Research Papers Prof. Mechoulam Bio Contact Us Careers Media HE About Our Story Board of Directors Executive Leadership Advisory Board Treatments Current Developments Prader-Willi Syndrome Psoriasis Inflammatory Bowel Disease Science About Cannabiniod Acids Pipeline Key Collaborations Research Papers Prof. Mechoulam Bio Careers Media Contact Us EPM’s Medicine Revolution Medicine to All Novel therapeutics from synthetic cannabinoid acids for a healthier and brighter future Our Story Patient-focused Pharmaceutical Group EPM is developing prescription medicine based on novel discoveries of synthetic cannabinoid acids to address unmet patient needs. These innovations represent new treatment options and aim at alleviating a wide range of therapeutic conditions for |
HTTP/1.1 308 Permanent Redirect Date: Sat, 30 Oct 2021 20:39:18 GMT Content-Type: text/plain Connection: keep-alive Location: https://epmip.com/ Refresh: 0;url=https://epmip.com/ server: Vercel x-vercel-id: cle1::2xvwg-1635626358038-c605f71f6ed3 HTTP/2 200 content-type: text/html; charset=utf-8 x-matched-path: / cache-control: public, max-age=0, must-revalidate content-length: 0 date: Sat, 30 Oct 2021 20:39:19 GMT x-powered-by: Next.js etag: "2529b-qCIuIcT5U/G0IkV8fQ6tkubNPRw" x-vercel-cache: MISS age: 0 server: Vercel x-vercel-id: cle1::iad1::dm6nh-1635626358094-27e8e3e7e1ed strict-transport-security: max-age=63072000 |
Domain Name: EPMIP.COM Registry Domain ID: 2400544449_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-06-11T16:46:50Z Creation Date: 2019-06-10T10:32:45Z Registry Expiry Date: 2022-06-10T10:32:45Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS75.DOMAINCONTROL.COM Name Server: NS76.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T06:57:15Z <<< |